semaglutide columbus Weight Loss Clinic We are excited to announce

Semaglutide, a selective GLP-1 receptor agonist marketed as Ozempic, Wegovy, and Rybelsus, is one of the most extensively studied anti-obesity and anti-diabetes medications in history, with over 25,000 clinical trial participants and FDA approval for three distinct indications

Over time, the buildup of fat in the liver can lead to inflammation, fibrosis (liver scarring), cirrhosis, liver cancer and the need for a liver transplant

doi: 10.2337/db13-1660

Despite all the evidence-based information and available FDA-approved anti-obesity medications, people who have a higher weight encounter difficulty accessing or receiving the care they deserve

Understanding the many factors that affect urine helps avoid wrong assumptions about side effects

This is referred to as metabolic flexibility